WASHINGTON: An Indian drug manufacturer has agreed to plead guilty to concealing and destroying records prior to a 2013 US Food and Drug Administration's inspection of its plant and pay USD 50 million ...

An Indian drug manufacturer has agreed to pay $50 million in fines and forfeitures, the US Department of Justice announced Tuesday. Fresenius Kabi Oncology Limited (FKOL) plead guilty to concealing ...

An Indian drug manufacturer has been sentenced to pay $50 million in fines and forfeiture after pleading guilty to concealing and destroying records prior to a 2013 US Food and Drug Administration ...

The AIDS and TB medicines would join a list of nearly 400 essential drugs under price control in India. Photo: Ramesh Pathania/Mint An Indian drug manufacturer has been sentenced to pay USD 50 million ...

Fresenius Kabi Oncology Limited admitted that it was guilty of the charge of violating the Federal Food, Drug and Cosmetic Act by failing to provide certain records to the U.S. Food and Drug ...

Washington: An Indian drug manufacturer has agreed to plead guilty to concealing and destroying records prior to a 2013 US Food and Drug Administration's inspection of its plant and pay USD 50 million ...

An Indian drug manufacturer will pay $50 million in fines and forfeiture after pleading guilty to hiding and destroying records ahead of a 2013 plant inspection by the Food and Drug Administration.

The company has pleaded guilty to violating the Federal Food, Drug and Cosmetic Act by failing to provide certain records to FDA investigators and will pay a criminal fine of $30 million, and forfeit ...

Indian Drugmaker To Pay $50 Million Fine In US For Irregularities Fresenius Kabi Oncology Limited (FKOL) was charged with violating the Federal Food, Drug and Cosmetic Act by failing to provide ...

WASHINGTON: An Indian drug manufacturer has been sentenced to pay USD 50 million in fines and forfeiture after pleading guilty to concealing and destroying records prior to a 2013 US Food and Drug ...

FKOL owned and operated a manufacturing plant in Kalyani, West Bengal, that manufactured active pharmaceutical ingredients (APIs) used in various cancer drug products distributed to the United States.